IACR Newsflash

New guidelines on staging of paediatric cancers

New Paediatric Non-Stage Prognosticator Guidelines & an update of 2014 Toronto Stage Guidelines by the International Agency for Research on Cancer (IARC) & partners have been published. 

The guidelines were developed by a panel of international experts and stakeholders during a meeting held at IARC, covering the collection of standardized information, which facilitates the interpretation and comparison of data on survival and mortality across regions and over time. The panel also reviewed and updated the 2014 Toronto Paediatric Cancer Stage Guidelines.

Read the article in the Lancet Oncology here:  Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage Guidelines



New ENCR Representative to IACR

Following the end of term of Dr. Michael Eden (Public Health England) at the Steering Committee of the European Network of Cancer Registries (ENCR), it is our pleasure to announce to the IACR Membership that Dr. Volker Arndt has been appointed as the new ENCR Representative for IACR.  As ENCR Representative, Dr Arndt joins the IACR Board of Directors.

Dr Volker Arndt is currently the Director of Epidemiological Cancer Registry Baden-Württemberg, German Cancer Research Center, Heidelberg, Germany and also serves as Head of Unit of Cancer Survivorship, German Cancer Research Center in Heidelberg.

Welcome to the IACR Board, Dr Volker Arndt and many thanks to Michael Eden!


Haematological Malignancies in Belgium, 2004-2018

Our colleagues at the Belgian Cancer Registry (BCR) are pleased to share their new E-book publication, Haematological Malignancies - Belgium 2004-2018.

This publication is the result of close collaboration between the BCR and the Belgian Hematology Society (BHS) and of a partnership with the Belgian Society of Paediatric Haematology Oncology (BSPHO).

This e-book describes the epidemiological situation of haematological malignancies in Belgium for 15 consecutive years of incidence data. In addition to results on incidence, prevalence, 5-year survival and trends as presented in the last publication on haematological malignancies in 2015, this new publication will also include incidence projections until 2025 and 10-year relative survival for the main haematological subtypes.

The E-book can be downloaded through this link: 

The e-book is available through the link here: HM 20014-2018 E-Book 

or through the BCR's Publications page. 


IACR congratulates our colleagues at the Belgian Cancer Registry and the clinical societies they worked with to produce this impressive report.




Dr Jacques Estève: A Tribute

We at IACR announce the passing of our colleague Dr. Jacques Estève who passed away on 20 February 2022.

He was a titan in the field of descriptive epidemiology, and continues to have a huge influence on our daily work. Dr Estève worked at the IARC from 1977 served as its Head of Biostatistics Research and Informatics.  He was a remarkable mathematician and described new methods to calculate cancer survival and to estimate national cancer incidence rates using national and regional cancer mortality data. Dr Estève edited or made important contributions to many of  IARC's Scientific Publications, most notably:

Read IARC's obituary here.

Prof John L. Young: A Tribute

Dr John L Young 2021With deep sadness, NAACCR and IACR announce the passing of our colleague, IACR Honorary MemberDr. John L Young Jr. on 11 March 2021.

He served as IACR General Secretary in 1983 -1986 and President in 1996 - 1999. 

John is considered to be the “father” of cancer surveillance in North America and instrumental to establishing and advancing the principles of this field worldwide.  While serving in the Public Health Service, he was employed at the National Cancer Institute 50 years ago during the establishment of the Surveillance, Epidemiology and End Results (SEER) Program. Working with Charles Smart, William Haenzel, Sidney Cutler, and Constance Percy, among others, John defined the rules and standard operating procedures for the SEER Program, and ultimately the nation and the world. He also worked closely with Calum Muir and Max Parkin at the International Association of Cancer Registries (IACR), serving as President, as an editor of Cancer in Five Continents (Volume VII), and as an advisor to population based registries worldwide. CI5 VII Dr Young 2021

Through this work, the first standardized and aggregated cancer incidence data were published on a national and international scale, leading to the foundation of descriptive cancer epidemiology and the study of regional variation in cancer incidence. He led the SEER Program until retiring from the Public Health Service in the late 1980s when he moved to California to lead the establishment of the Greater California Cancer Registry with others such as Don Austin and Dee West.  During his tenure in California, John played a pivotal role in the establishment of the North American Association of Central Cancer Registries (NAACCR), and served as its first President.  In the 1990s John joined the faculty of Emory University in Atlanta and served as the Director of the Atlanta SEER registry, and as an advisor to the National Program of Cancer Registries at the Centers for Disease Control and Prevention.

More important than all of these significant achievements and contributions to the science of cancer surveillance, John served as a mentor and advisor to us all. Without text books or formal training programs in cancer registration and cancer surveillance John shared his knowledge and opinions freely guiding hundreds of cancer surveillance professionals. His tag line about data quality, “Purification Through Use”, still resonates with us today.  John was cancer surveillance’s equivalent of Dr. Anthony Fauci.

Finally, John will be remembered as a man with an enormous heart, generous spirit and witty sense of humor.  John dearly loved his family, friends and colleagues and found many ways to enrich our lives both professionally and privately.  He will be sorely missed and long remembered as friend, a mentor, and for his positive influence on us all.


Page 3 of 6

Our partners

120507 01b LOGO X3





This website was developed and is hosted at the International Agency for Research on Cancer (IARC)
Go to top